• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Johnson & Johnson Vision

Johnson & Johnson has a new head of Vision Care

November 27, 2024 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) announced that it appointed Shawn Millerick as president of Vision Care, Americas. Millerick’s appointment went into effect on Nov. 11, 2024. He holds responsibility for defining strategy and driving growth for the company’s Vision Care portfolio in North America and LATAM. That includes the world’s leading contact lens family, Acuvue. Johnson […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Vision Tagged With: Johnson & Johnson, Johnson & Johnson MedTech, Johnson & Johnson Vision, Personnel Moves

Johnson & Johnson launches new intraocular lens in EMEA

February 15, 2024 By Sean Whooley

Johnson & Johnson MedTech announced that its Vision unit made the Tecnis PureSee lens available in the EMEA region. Tecnis PureSee is a purely refractive, presbyopia-correcting intraocular lens (IOL). It features a proprietary design aimed at delivering uninterrupted, high-quality vision. Johnson & Johnson says it offers high best-in-category contrast and low-light performance compared to a […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Vision Tagged With: Johnson & Johnson, Johnson & Johnson MedTech, Johnson & Johnson Vision

Bausch + Lomb makes another eye drop acquisition

July 6, 2023 By Sean Whooley

Bausch + Lomb (NYSE:BLCO) announced today that an affiliate purchased the Blink product line from Johnson & Johnson Vision. The over-the-counter Blink product line features eye and contact lens drops, marking another eye care acquisition for Bausch + Lomb. Last week, the company acquired eye drops and a delivery system from Novartis in a deal worth up to […]

Filed Under: Business/Financial News, Drug-Device Combinations, Mergers & Acquisitions, News Well, Optical/Ophthalmic, Vision Tagged With: Bausch + Lomb, Johnson & Johnson Vision

Johnson & Johnson Vision launches overnight, intraocular lenses

September 28, 2022 By Sean Whooley

Johnson & Johnson Vision announced today that it launched an expanded range of Acuvue Abiliti overnight lenses, as well as a new intraocular lens. The FDA approved an expanded range of the Acuvue Abiliti overnight therapeutic lenses for myopia (nearsightedness) management. The approval covers lenses up to six diopters, widening the range from the previously approved […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), News Well, Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Johnson & Johnson, Johnson & Johnson Vision

5 top ophthalmic device innovations you need to know

September 27, 2022 By Sean Whooley

Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space. It may not be a new wave, but medtech companies continue to improve upon technologies for the human eye. Implants, lenses and more comprise the space’s latest innovations, with a number of companies finding new ways to fix old […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, News Well, Optical/Ophthalmic Tagged With: Alcon, Bausch + Lomb, Clearside Biomedical, Glaukos, Johnson & Johnson, Johnson & Johnson Vision, Sight Sciences

Report: J&J Vision spending €100 million to expand Irish facility

September 20, 2022 By Sean Whooley

J&J Vision reportedly plans to invest €100m in the expansion of its Plassey, Limerick, Ireland facility. The Irish Examiner reported last week that the company plans to expand and create 80 new jobs at the location. In March, the company announced a €35 million investment in the same facility. That cash infusion aimed to create […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, News Well, Optical/Ophthalmic Tagged With: Ireland, Johnson & Johnson, Johnson & Johnson Vision

Johnson & Johnson Vision launches new contact lenses

September 12, 2022 By Sean Whooley

Johnson & Johnson Vision announced today that it launched its new Acuvue Oasys Max 1-day contact lenses and multifocal lenses for presbyopia. The lenses feature Johnson & Johnson’s TearStable technology for tear-film stability and locking in moisture. They also offer the OptiBlue light filter for filtering blue-violet to reduce light scatter for visual clarity. Johnson […]

Filed Under: Business/Financial News, Featured, News Well, Optical/Ophthalmic Tagged With: Johnson & Johnson, Johnson & Johnson Vision

6 drug delivery innovations you need to know

July 28, 2022 By Sean Whooley

From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Pharmaceutical, Software / IT Tagged With: Abbott, BD, Bigfoot Biomedical, CeQur, Cook Medical, Dexcom, drug delivery, Insulet, jabil, Johnson & Johnson, Johnson & Johnson Vision, Medtronic, NovaXS, PharmaJet, Phillips-Medisize, Senseonics, Vivera

Johnson & Johnson Vision wins Fast Company award for drug-eluting contact lens

May 4, 2022 By Sean Whooley

Johnson & Johnson Vision announced today that it was named a winner of Fast Company’s 2022 World Changing Ideas Awards. The eye health business arm of Johnson & Johnson (NYSE: JNJ) received the award in the “Wellness” category for its Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen). The drug-eluting contact, which provides a new wearing experience […]

Filed Under: Business/Financial News, Drug-Device Combinations, Optical/Ophthalmic Tagged With: Johnson & Johnson, Johnson & Johnson Vision

J&J is bringing the world’s first drug-eluting contact lens to market

March 21, 2022 By Sean Whooley

J&J has a potential alternative to eye drops with its drug-eluting Acuvue Theravision contact lens. As far back as the early 1960s, researchers toyed with the idea of delivering medication through contact lenses. Johnson & Johnson Vision (NYSE:JNJ) Director of Clinica Science Dr. Brian Pall told Drug Delivery Business News that patents back then disclosed how a soft […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Optical/Ophthalmic, Pharmaceutical, Regulatory/Compliance Tagged With: FDA, Johnson & Johnson, Johnson & Johnson Vision

FDA approves Johnson & Johnson Vision’s drug-eluting contact lens

March 2, 2022 By Sean Whooley

Johnson & Johnson Vision announced today that it received FDA approval for its Acuvue Theravision with Ketotifen. The eye health business arm of Johnson & Johnson (NYSE:JNJ) designed Acuvue Theravision with ketotifen (etafilcon A drug-eluting contact lens with ketotifen) to provide a new wearing experience for contact lens wearers who have allergic eye itch for up to 12 […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), News Well, Optical/Ophthalmic, Pharmaceutical, Regulatory/Compliance Tagged With: Johnson & Johnson, Johnson & Johnson Vision

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy